MSCs significantly reduced the levels of inflammatory cytokines (IL-6, IFN-γ, and TNF-α) in BALF to promote lung injury repair, which is consistent with the previous finding that blocking TNF-α attenuated the severity of LPS-induced ALI 33. Here, IL6 is linked to acute respiratory distress syndrome.